Together, these results from multiple cohorts of cell lines and patient tumor samples support the cooperative roles of SMARCA4/2 in regulating ITPR3 and confirm reduced IP3R3 expression in SMARCA4/2-deficient cancers. Here, SMARCA4 is linked to cancer.